D

Day One Biopharmaceuticals Inc
NASDAQ:DAWN

Watchlist Manager
Day One Biopharmaceuticals Inc
NASDAQ:DAWN
Watchlist
Price: 13.72 USD 2.85% Market Closed
Market Cap: 1.4B USD
Have any thoughts about
Day One Biopharmaceuticals Inc?
Write Note

Cash Flow Statement

Cash Flow Statement
Day One Biopharmaceuticals Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Operating Cash Flow
Net Income
(44)
(58)
(71)
(86)
(73)
(84)
(105)
(124)
(142)
(157)
(166)
(175)
(189)
(209)
(167)
(84)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
Stock-Based Compensation
1
1
4
9
13
19
22
26
27
30
34
35
39
43
46
0
Other Non-Cash Items
31
39
41
46
22
19
22
25
26
28
27
29
33
35
(65)
(10)
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
Change in Working Capital
(0)
(2)
(3)
(1)
3
5
6
11
7
14
12
4
9
3
55
4
Cash from Operating Activities
(13)
N/A
(21)
-57%
(33)
-55%
(41)
-26%
(49)
-18%
(60)
-24%
(77)
-27%
(88)
-14%
(110)
-25%
(114)
-4%
(127)
-11%
(141)
-11%
(147)
-4%
(171)
-16%
(177)
-4%
(89)
+50%
Investing Cash Flow
Capital Expenditures
(0)
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(17)
(18)
Other Items
0
(8)
(8)
(8)
(8)
0
(6)
(253)
(255)
(266)
(240)
96
129
229
243
87
Cash from Investing Activities
(0)
N/A
(8)
-8 789%
(8)
N/A
(8)
N/A
(8)
N/A
(0)
+100%
(6)
-29 950%
(253)
-4 107%
(255)
-1%
(266)
-4%
(240)
+10%
96
N/A
128
+34%
229
+78%
226
-1%
69
-69%
Financing Cash Flow
Net Issuance of Common Stock
30
160
327
327
297
167
162
164
166
167
167
165
164
163
2
24
Other
0
(1)
0
0
0
0
0
0
0
0
0
0
0
0
0
178
Cash from Financing Activities
30
N/A
159
+430%
327
+106%
327
0%
297
-9%
168
-43%
162
-4%
164
+2%
166
+1%
167
+1%
167
+0%
165
-1%
164
-1%
163
-1%
2
-99%
202
+9 746%
Change in Cash
Net Change in Cash
16
N/A
130
+691%
287
+121%
277
-3%
241
-13%
108
-55%
79
-27%
(176)
N/A
(199)
-13%
(213)
-7%
(200)
+6%
120
N/A
146
+21%
221
+52%
50
-77%
182
+260%
Free Cash Flow
Free Cash Flow
(14)
N/A
(21)
-56%
(33)
-55%
(41)
-26%
(49)
-18%
(60)
-24%
(77)
-27%
(88)
-14%
(110)
-25%
(114)
-4%
(127)
-11%
(141)
-11%
(147)
-4%
(171)
-16%
(194)
-14%
(107)
+45%

See Also

Discover More